Synopsis
Pancreatic ductal adenocarcinoma (PDAC) is a significant cause of cancer-related deaths. A previous study showed that combination therapy with high-dose radiotherapy and an anti-CTLA-4 anti-body (C4) enhanced distant anti-tumor effects, referred to as the abscopal effect. Hyperthermia (HT) enhances the anti-tumor effects in combination with radiotherapy (RT) or chemotherapy. However, the local and abscopal effects of RT with HT combined with C4 therapy for PDAC re-main unclear. Here, we investigated whether combination therapy with HT, RT, and C4 is an effective therapeutic strategy for PDAC. Murine PDAC cells were inoculated into both legs of C57BL/6 mice, and the mice were treated only one leg with HT and/or RT. C4 was administered intraperito-neally every 3 days for a total of three doses. According to in vitro experiments, the radiosensitizing effect of HT was approximately 23%. In vivo experiments, no radiosensitizing or abscopal effect of HT to 10 Gy of RT was obtained, and the same results were observed when C4 was used in combi-nation. However, the dose escalation to 14 Gy with HT and C4 induced the abscopal effect. These results suggest that the radiosensitizing effect of HT plays a role not only at local sites, but also at abscopal sites via C4. Further studies using more focal and high-temperature HT (eg; magnetic nanomaterial-based HT) may unveil enhanced therapeutic efficacy and safety.
Key words:radiation therapy, hyperthermia, immune checkpoint inhibitor, abscopal effect, pancreatic cancer